Register for this Webinar to Learn More
The Most Favored Nation (MFN) drug pricing policy represents a rare convergence of political uncertainty, global pricing pressure, and long-term strategic risk for biopharmaceutical companies. While its timing and final form remain uncertain, the range of plausible outcomes is broad and highly consequential—challenging traditional forecasting and linear planning approaches.
This webinar examines MFN through the lens of strategic scenario planning. Drawing on established foresight methodologies adapted for biopharma, the session explores how organizations can systematically assess MFN-driven futures, integrate macroeconomic and policy uncertainty, and develop strategic options that remain viable across divergent scenarios. Topics include navigating alternative MFN futures, selecting the appropriate scenario planning approach, anticipating stakeholder responses to uncertain trends, and using early warning signposts to guide decision-making as policy conditions evolve.
Offered Free by: Syneos Health
See All Resources from: Syneos Health
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.





